Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AbbVie Inc. Director's Dealing 2016

Feb 22, 2016

29755_dirs_2016-02-22_be1b1a13-d857-4d2a-9104-560a45194242.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2016-02-18

Reporting Person: HURWICH THOMAS A. (VP, Controller)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-02-18 Option (right to buy) $54.86 A 15110 Acquired 2026-02-17 Common shares (15110) Direct

Footnotes

F1: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 5,037 on 02/18/2017, 5,036 on 02/18/2018, and 5,037 on 02/18/2019.